Since the tumor environment influences, at least in part, the tumor growth capability of cancer cells, we performed an in vivo genome‐wide CRISPR‐Cas9 SAM screen to identify in vivo tumor‐promoting genes, defined as genes whose expression support tumor growth (in contrast to driver genes bearing a driver mutation such as BRAF (V600E)). The gene discussed is BRAF; the disease is cancer.